326 related articles for article (PubMed ID: 36087245)
1. Extracellular Vesicles Derived from Mesenchymal Stem Cells: A Potential Biodrug for Acute Respiratory Distress Syndrome Treatment.
Sun H; Zhang T; Gao J
BioDrugs; 2022 Nov; 36(6):701-715. PubMed ID: 36087245
[TBL] [Abstract][Full Text] [Related]
2. Endothelial cell-derived extracellular vesicles modulate the therapeutic efficacy of mesenchymal stem cells through IDH2/TET pathway in ARDS.
Wu X; Tang Y; Lu X; Liu Y; Liu X; Sun Q; Wang L; Huang W; Liu A; Liu L; Chao J; Zhang X; Qiu H
Cell Commun Signal; 2024 May; 22(1):293. PubMed ID: 38802896
[TBL] [Abstract][Full Text] [Related]
3. Effects of mesenchymal stromal cell-derived extracellular vesicles in acute respiratory distress syndrome (ARDS): Current understanding and future perspectives.
Su Y; Guo H; Liu Q
J Leukoc Biol; 2021 Jul; 110(1):27-38. PubMed ID: 33955590
[TBL] [Abstract][Full Text] [Related]
4. Mesenchymal stromal cell extracellular vesicles rescue mitochondrial dysfunction and improve barrier integrity in clinically relevant models of ARDS.
Dutra Silva J; Su Y; Calfee CS; Delucchi KL; Weiss D; McAuley DF; O'Kane C; Krasnodembskaya AD
Eur Respir J; 2021 Jul; 58(1):. PubMed ID: 33334945
[TBL] [Abstract][Full Text] [Related]
5. Advances of mesenchymal stem cells and their derived extracellular vesicles as a promising therapy for acute respiratory distress syndrome: from bench to clinic.
Zhuang X; Jiang Y; Yang X; Fu L; Luo L; Dong Z; Zhao J; Hei F
Front Immunol; 2023; 14():1244930. PubMed ID: 37711624
[TBL] [Abstract][Full Text] [Related]
6. Human Placental Mesenchymal Stem Cells and Derived Extracellular Vesicles Ameliorate Lung Injury in Acute Respiratory Distress Syndrome Murine Model.
Valiukevičius P; Mačiulaitis J; Pangonytė D; Siratavičiūtė V; Kluszczyńska K; Kuzaitytė U; Insodaitė R; Čiapienė I; Grigalevičiūtė R; Zigmantaitė V; Vitkauskienė A; Mačiulaitis R
Cells; 2023 Nov; 12(23):. PubMed ID: 38067158
[TBL] [Abstract][Full Text] [Related]
7. Mesenchymal stromal/stem cells (MSCs) and MSC-derived extracellular vesicles in COVID-19-induced ARDS: Mechanisms of action, research progress, challenges, and opportunities.
Moradinasab S; Pourbagheri-Sigaroodi A; Zafari P; Ghaffari SH; Bashash D
Int Immunopharmacol; 2021 Aug; 97():107694. PubMed ID: 33932694
[TBL] [Abstract][Full Text] [Related]
8. Mesenchymal stromal cells-derived extracellular vesicles reprogramme macrophages in ARDS models through the miR-181a-5p-PTEN-pSTAT5-SOCS1 axis.
Su Y; Silva JD; Doherty D; Simpson DA; Weiss DJ; Rolandsson-Enes S; McAuley DF; O'Kane CM; Brazil DP; Krasnodembskaya AD
Thorax; 2023 Jun; 78(6):617-630. PubMed ID: 35948417
[TBL] [Abstract][Full Text] [Related]
9. Differential effects of extracellular vesicles from aging and young mesenchymal stem cells in acute lung injury.
Huang R; Qin C; Wang J; Hu Y; Zheng G; Qiu G; Ge M; Tao H; Shu Q; Xu J
Aging (Albany NY); 2019 Sep; 11(18):7996-8014. PubMed ID: 31575829
[TBL] [Abstract][Full Text] [Related]
10. Mesenchymal stem cell-derived extracellular vesicles for the treatment of acute respiratory distress syndrome.
Abraham A; Krasnodembskaya A
Stem Cells Transl Med; 2020 Jan; 9(1):28-38. PubMed ID: 31647191
[TBL] [Abstract][Full Text] [Related]
11. Allogenic mesenchymal stromal cells and their extracellular vesicles in COVID-19 induced ARDS: a randomized controlled trial.
Zarrabi M; Shahrbaf MA; Nouri M; Shekari F; Hosseini SE; Hashemian SR; Aliannejad R; Jamaati H; Khavandgar N; Alemi H; Madani H; Nazari A; Amini A; Hassani SN; Abbasi F; Jarooghi N; Fallah N; Taghiyar L; Ganjibakhsh M; Hajizadeh-Saffar E; Vosough M; Baharvand H
Stem Cell Res Ther; 2023 Jun; 14(1):169. PubMed ID: 37365605
[TBL] [Abstract][Full Text] [Related]
12. Mesenchymal stromal cells for acute respiratory distress syndrome (ARDS), sepsis, and COVID-19 infection: optimizing the therapeutic potential.
Gorman E; Millar J; McAuley D; O'Kane C
Expert Rev Respir Med; 2021 Mar; 15(3):301-324. PubMed ID: 33172313
[No Abstract] [Full Text] [Related]
13. Mesenchymal stem cells-derived extracellular vesicles in acute respiratory distress syndrome: a review of current literature and potential future treatment options.
Shah TG; Predescu D; Predescu S
Clin Transl Med; 2019 Sep; 8(1):25. PubMed ID: 31512000
[TBL] [Abstract][Full Text] [Related]
14. The MSC-EV-microRNAome: A Perspective on Therapeutic Mechanisms of Action in Sepsis and ARDS.
Dos Santos CC; Lopes-Pacheco M; English K; Rolandsson Enes S; Krasnodembskaya A; Rocco PRM
Cells; 2024 Jan; 13(2):. PubMed ID: 38247814
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic Use of Extracellular Vesicles for Acute and Chronic Lung Disease.
Worthington EN; Hagood JS
Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32230828
[TBL] [Abstract][Full Text] [Related]
16. Extracellular vesicles in the pathogenesis and treatment of acute lung injury.
Hu Q; Zhang S; Yang Y; Yao JQ; Tang WF; Lyon CJ; Hu TY; Wan MH
Mil Med Res; 2022 Nov; 9(1):61. PubMed ID: 36316787
[TBL] [Abstract][Full Text] [Related]
17. MSC-NTF (NurOwn®) exosomes: a novel therapeutic modality in the mouse LPS-induced ARDS model.
Kaspi H; Semo J; Abramov N; Dekel C; Lindborg S; Kern R; Lebovits C; Aricha R
Stem Cell Res Ther; 2021 Jan; 12(1):72. PubMed ID: 33468250
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic potential of mesenchymal stem cell-derived extracellular vesicles as novel cell-free therapy for treatment of autoimmune disorders.
Kahmini FR; Shahgaldi S
Exp Mol Pathol; 2021 Feb; 118():104566. PubMed ID: 33160961
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic potential of mesenchymal stem/stromal cell-derived secretome and vesicles for lung injury and disease.
Liu A; Zhang X; He H; Zhou L; Naito Y; Sugita S; Lee JW
Expert Opin Biol Ther; 2020 Feb; 20(2):125-140. PubMed ID: 31701782
[No Abstract] [Full Text] [Related]
20. Anti-inflammatory Effects of Mesenchymal Stem Cells and their Secretomes in Pneumonia.
Hezam K; Mo R; Wang C; Liu Y; Li Z
Curr Pharm Biotechnol; 2022; 23(9):1153-1167. PubMed ID: 34493193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
